Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-040107
Filing Date
2023-06-28
Accepted
2023-06-28 21:00:13
Documents
2
Period of Report
2023-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4036
2 POA DOCUMENT poa.txt EX-24 3100
  Complete submission text file 0001209191-23-040107.txt   8602
Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Islam Saqib (Reporting) CIK: 0001575408 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 231053975

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations